Literature DB >> 9755358

MN blood groups and bipolar disorder: evidence of genotypic association and Hardy-Weinberg disequilibrium.

M Alda1, P Grof, E Grof.   

Abstract

BACKGROUND: MN blood groups have been studied in the past as a genetic marker of biopolar disorder (BD). Several previous studies reported an association of the illness with lower frequency of blood group NN.
METHODS: We analyzed distribution of MN blood groups in a sample of 174 patients with BD, 176 with unipolar depression, 98 with schizophrenia, and 331 healthy controls. In addition, we tested whether the inferred genotypes. conform to Hardy-Weinberg equilibrium (HWE).
RESULTS: The frequency of NN phenotype was significantly lower among the bipolar patients than in any of the other three groups (p < .001). The genotype frequencies in the BD group deviated significantly from those expected under HWE (p < .01).
CONCLUSIONS: These results suggest a possible locus on chromosome 4 (4q28-q31.1) associated with genetic susceptibility to bipolar illness.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9755358     DOI: 10.1016/s0006-3223(98)00013-4

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  5 in total

Review 1.  The promise and reality of pharmacogenetics in psychiatry.

Authors:  Peter P Zandi; Jennifer T Judy
Journal:  Psychiatr Clin North Am       Date:  2010-03

Review 2.  Pharmacogenetics of lithium response in bipolar disorder.

Authors:  M Alda
Journal:  J Psychiatry Neurosci       Date:  1999-03       Impact factor: 6.186

Review 3.  Genetics of bipolar affective disorder.

Authors:  J I Nurnberger; T Foroud
Journal:  Curr Psychiatry Rep       Date:  2000-04       Impact factor: 5.285

Review 4.  Lithium in the treatment of bipolar disorder: pharmacology and pharmacogenetics.

Authors:  M Alda
Journal:  Mol Psychiatry       Date:  2015-02-17       Impact factor: 15.992

5.  Lithium: a key to the genetics of bipolar disorder.

Authors:  Cristiana Cruceanu; Martin Alda; Gustavo Turecki
Journal:  Genome Med       Date:  2009-08-19       Impact factor: 11.117

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.